Home/Filings/4/0000899243-22-022621
4//SEC Filing

Vittiglio Joseph 4

Accession 0000899243-22-022621

CIK 0001733257other

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 5:05 PM ET

Size

5.0 KB

Accession

0000899243-22-022621

Insider Transaction Report

Form 4
Period: 2022-06-13
Vittiglio Joseph
Chief Business & Legal Officer
Transactions
  • Award

    Common Stock

    2022-06-13+35,00035,000 total
Footnotes (1)
  • [F1]Represents restricted stock units ("RSUs"). One third (1/3) of the total number of RSUs granted vest on October 20, 2022, February 20, 2023 and June 20, 2023, subject to the Reporting Person's continued service on each applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

Issuer

Finch Therapeutics Group, Inc.

CIK 0001733257

Entity typeother

Related Parties

1
  • filerCIK 0001551776

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 5:05 PM ET
Size
5.0 KB